GIVE YOUR STUDY A NEW LOOK

Animascope is a company providing multimodality imaging services to international customers. Animascope experts have several years of experience in discovery and preclinical imaging in vivo.

In vivo imaging has become a cornerstone in clinical and preclinical studies. Non-invasive technologies facilitate studies of structures, functions and dysfunctions through real-time acquisition, processing and quantification of whole-body images.

Preclinical imaging is suitable for phenotyping, for model validation and for biodistribution studies, as well as for assessment of drug. The company, based in the Rhône-Alpes region of France, was founded in 2008 by a team of experts in the field of in vivo medical imaging and laboratory animal sciences.

In biomedical research, in vivo imaging is applicable to exploratory research, and bridges the gap between preclinical and clinical research. Imaging is particularly useful for pathophysiology, phenotyping and model validation studies.

Medical imaging is applicable to dynamic biodistribution and biomarker validation studies, and is also used to assess the delivery, liberation, efficacy and safety of drugs, biologics, biopharmaceuticals, nanoparticles, biomaterials and stem cells. Imaging can assist in risk assessment and reproductive toxicology of various safety and efficacy in several therapeutic fields. Non-invasive in vivo imaging is a cost and time-effective approach to streamline R&D and increase predictability of clinical outcomes. With multi-modality imaging, multiple experimental readouts (anatomy, biodistribution, efficacy, safety and kinetics) are available within the frame of the same study, in the same anatomical context. Whole-body studies are performed within days.